Guideline-directed medical therapies for diabetic kidney disease among Thai people with type 2 diabetes: A real-world data based on Theptarin Diabetes Staging

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20251014008

Enrollment

206

Registered

2025-10-14

Start date

2021-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To evaluate the rate of guideline-directed medical therapies in diabetic kidney disease Guideline-directed medical therapies (GDMT) Prescription rates Diabetic kidney disease Thai Theptarin Diabetes Staging

Interventions

Patient received guideline-directed medical therapies for diabetic kidney disease 2-4 drugs,Patient received guideline-directed medical therapies for diabetic kidney disease 0-1 drug

Treatment,Treatment

GDMT2-4,GDMT0-1

Eligibility

Sex/Gender

All

Age

15 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with TDS stage 4Ka, 4Kb, and Stage 5Ka who were regularly followed-up at least 3 times in 2021

Exclusion criteria

Exclusion criteria: 1. Patients ages < 15 years or > 80 years 2. Patients with normoalbuminuria 3. eGFR < 20 mL/min/1.73 m2 4. Patients with type 1 diabetes mellitus and other types of diabetes

Design outcomes

Primary

Measure	Time frame
Rate of prescription End of study Percentage	—

Secondary

Measure	Time frame
Stage changes in Theptarin Diabetes Staging End of study Theptarin Diabetes Staging	—

Countries

Thailand

Contacts

Public ContactPeachaphol Chongvoranond

Vimut Theptarin

peachapl@hotmail.com66863929687

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026